top of page

News of Note - March 3-4, 2023

BULL BEAR BRES|NAHAN

Saturday, March 4, 2023

As of --> 09:10 EET




Programming update, the next week or two will see a pause in this, I know, we only just restarted sending stuff out into the ether.. Personal/ family business to tend to.. See you on the other side..


In healthcare land you're seeing pharma start to push back, could get interesting out there; seems they're not in the mood to be pushed around any longer..


As Art Cashin says, stay nimble..


And let me add, don’t whipsaw yourself!!


😊


Br. -john



 


*PRESS RELEASES*


KROS

Keros Therapeutics [bio]


Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results



LLY

Eli Lilly [cc: PFE & NOVN SW | NVS]


U.S. FDA Broadens Indication for Verzenio® (abemaciclib) in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer



BMY

Bristol Myers Squibb


Receives European Commission Approval of Reblozyl® (luspatercept) for Anemia in Adult Patients with Non-Transfusion-Dependent Beta Thalassemia

  • Third authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with diseases impacted by anemia



VERV

Verve Therapeutics [bio]


Reports New Preclinical Data Demonstrating Potent and Durable Editing of ANGPTL3 Gene with VERVE-201 in Wild-type and LDLR-deficient Non-Human Primates



SAABB SS

Saab


Receives Carl-Gustaf Ammunition Order from Lithuania



HNSA SS

Hansa [bio]


Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma



EQNR NO | EQNR

Equinor


Acquires Suncor Energy UK



ERICA SS | ERICB SS | ERIC

Ericsson


U.S. Department of Justice Resolves 2019 Deferred Prosecution Agreement Breaches with Ericsson



ARDX

Ardelyx [bio]


Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update



HII

Huntington Ingalls Industries


HII and Ocean Aero to Partner on Advanced Unmanned Maritime Capabilities



ILMN & MYGN

Illumina & Myriad Genetics


Expand partnership to broaden access to HRD testing in the United States

  • Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry



AZN SS | AZN LN | AZN & MRK

AstraZeneca & Merck


Update on US regulatory review of Lynparza in combination with abiraterone for mCRPC



PHIA NA | PHG

Koninklijke (Royal) Philips


Showcases comprehensive cardiology portfolio designed to increase physician confidence and efficiency in diagnosing and treating cardiac disease at ACC/WCC 2023



GEHC

GE HealthCare


Advantus Health Partners and GE HealthCare Announce Multi-Year Agreement to Expand Access to Healthcare Technology Management Services

  • The two companies will offer healthcare organizations a holistic program that goes beyond the traditional break-fix approach to medical device maintenance

  • Advantus Health Partners will leverage the expanded relationship to support quality care and sustainable cost reductions for its clients



MTNB

Matinas BioPharma [bio]


Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID



BMY & JNJ

Bristol Myers Squibb & Janssen (J&J)


Collaboration Launches Pivotal Phase 3 Librexia Clinical Trial Program Evaluating Milvexian, an Investigational Oral Factor XIa Inhibitor



VERV

Verve Therapeutics [bio]


Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results



MOR GY | MOR

MorphoSys [bio]


Stops Work and Operations on Pre-Clinical Research Programs




 



*ARTICLES, ETC.*



Endpoints


UK and pharma (generic and branded) going to war..


UK government plans to hike revenue clawback rates beginning in April


Roche, Exelixis' Tecentriq/Cabometyx combo flunks second PhIII



Nature


Pablo Escobar’s ‘cocaine hippos’ spark conservation row

  • Researchers worry Colombian environment ministry will side with animal-rights activists rather than curb the invasive animals’ spread.



Bloomberg


What Now for a Fed That Has Fallen Behind the Curve Again?

  • The central bank downshifted rate increases too early and now faces a set of dilemmas and another knock to its credibility. - El-Erian


Who Owns Train Cars? Hint: Usually Not the Railroad

  • Private owners such as shippers and lessors account for about two-thirds of the cars operating on North American tracks, and maintenance obligations typically fall to them.


Blackstone Defaults on Nordic CMBS as Property Values Wobble

  • The notes are backed by a portfolio of offices and stores

  • Blackstone has been trying to sell the underlying properties


Toblerone Is Barred From Using the Iconic Swiss Mountain on Its Logo


Big Food Brands Struggling to Kick Junk Addiction, Survey Finds

  • Kraft Heinz, Nestle, Unilever, Kellogg rely on unhealthy food

  • Over 2,000 items sold in Australia, France, Mexico analyzed


Taylor Swift Boosts Universal Music’s Sales to $3.1 Billion

  • Universal Music Group’s sales rose 17% in the fourth quarter

  • Swift’s “Midnights” album sold over 6 million in eight weeks



Other


Ancient DNA upends European prehistory

  • Genes reveal striking diversity within similar ice age cultures


Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.


Viatris warns it will stop selling essential drugs in UK without changes to drug pricing agreement


AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates


World Obesity Atlas 2023

  • Obesity's global toll heads toward $4 trillion a year


How meningitis-causing bacteria invade the brain

  • Experiments in mice show the microbes hijack cells in the brain’s protective cover


Here’s how lemon juice may fend off kidney stones

  • Nanoparticles in the juice slowed the formation of the stones in rats


Evaluate


The sun sets on Exelixis’s pipeline in a product

  • After Cabometyx’s latest clinical setback Exelixis might have to turn to follow-on projects for future growth.


Spotlight – What is next in Nash

  • The next few months will see some important mid-stage Nash results, from Viking, 89Bio, Northsea and others.


GSK gets the vaccine edge on Pfizer

  • US experts favour GSK’s RSV vaccine over Pfizer’s, but both could be on the market soon.

bottom of page